
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $55.8M | -- | -- | $0.07 | -- |
08/05/2025 | Q2 | $59.7M | -- | -- | $0.09 | -- |
05/01/2025 | Q1 | $56.2M | $64.8M | $0.11 | $0.08 | $0.03 |
02/26/2025 | Q4 | $58.8M | $57.5M | $0.10 | $0.08 | $0.03 |
11/07/2024 | Q3 | $54.2M | $44.2M | -$2.02 | $0.06 | -$2.08 |
06/30/2024 | Q2 | $169.3M | $179M | $0.09 | $0.07 | $0.02 |
03/31/2024 | Q1 | $170.8M | $49M | $0.08 | $0.05 | $0.03 |
12/31/2023 | Q4 | $171.1M | $46.5M | -$0.01 | $0.08 | -$0.09 |
09/30/2023 | Q3 | $173.8M | $57.3M | $0.09 | $0.06 | $0.03 |
06/30/2023 | Q2 | -- | $183.3M | $0.02 | -- | -- |
03/31/2023 | Q1 | -- | $200M | $0.06 | -- | -- |
12/31/2022 | Q4 | -- | -$397.4M | $0.10 | -- | -- |
09/30/2022 | Q3 | -- | $219.9M | -$0.26 | -- | -- |
06/30/2022 | Q2 | -- | $194.1M | -$0.08 | -- | -- |
03/31/2022 | Q1 | -- | $176.4M | $0.03 | -- | -- |
12/31/2021 | Q4 | -- | $179.6M | -$0.04 | -- | -- |
09/30/2021 | Q3 | -- | $151.8M | -$0.11 | -- | -- |
06/30/2021 | Q2 | -- | $142.2M | -$0.07 | -- | -- |
03/31/2021 | Q1 | -- | $141.2M | -$0.06 | -- | -- |
12/31/2020 | Q4 | -- | $129.7M | -$0.20 | -- | -- |
09/30/2020 | Q3 | -- | $96.4M | -$0.26 | -- | -- |
06/30/2020 | Q2 | -- | $101.9M | -$0.29 | -- | -- |
03/31/2020 | Q1 | -- | $164.6M | -$0.14 | -- | -- |
12/31/2019 | Q4 | -- | $189.5M | -$0.19 | -- | -- |
09/30/2019 | Q3 | -- | $202.8M | -$0.02 | -- | -- |
06/30/2019 | Q2 | -- | $216.4M | $0.05 | -- | -- |
03/31/2019 | Q1 | -- | $211.5M | $0.01 | -- | -- |
12/31/2018 | Q4 | -- | $247.7M | $0.11 | -- | -- |
09/30/2018 | Q3 | -- | $235.3M | $0.04 | -- | -- |
06/30/2018 | Q2 | -- | $236.3M | $0.12 | -- | -- |
03/31/2018 | Q1 | -- | $227.3M | $0.08 | -- | -- |
12/31/2017 | Q4 | -- | $204.4M | -$0.11 | -- | -- |
09/30/2017 | Q3 | -- | $201.7M | $0.03 | -- | -- |
06/30/2017 | Q2 | -- | $183M | $0.02 | -- | -- |
03/31/2017 | Q1 | -- | $158.7M | -$0.01 | -- | -- |
12/31/2016 | Q4 | -- | $137.1M | -$0.00 | -- | -- |
09/30/2016 | Q3 | -- | $104.6M | -$0.16 | -- | -- |
06/30/2016 | Q2 | -- | $115.3M | -$0.17 | -- | -- |
03/31/2016 | Q1 | -- | $114.5M | -$0.16 | -- | -- |
12/31/2015 | Q4 | -- | $150.6M | -$1.00 | -- | -- |
09/30/2015 | Q3 | -- | $154.2M | -$0.05 | -- | -- |
NPK International reported $64.8M worth of top line sales in its most recent quarter.
NPK International announced earnings per share of $0.11 which represents a beat of analyst forecast a $0.08 per share.
NPK International reported $25.3M that represents $0.29 per share over the last quarter.
NPK International's earnings are forecast to grow from -$1.75 per share to $0.32 per share next year representing an increase of 85.29%.
NPK International's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.